U.S. Biotech Leaders Meet in Washington for Biotech Across America State Symposium

Biotechnology is increasingly important for U.S. national security and economic resilience. Biotech leaders from around the country joined NSCEB to chart state and local strategies for strengthening the future of U.S. biotech.

Photo courtesy of the National Security Commission on Emerging Biotechnology (NSCEB) LinkedIn Page

25, March 2026

FOR IMMEDIATE RELEASE

Washington, D.C. –Today, the National Security Commission on Emerging Biotechnology (NSCEB) gathered over 100 state and local officials, biotech industry leaders, and leading members of academia who are shaping biotechnology ecosystems across the country for the Biotech Across America State Symposium.

This event builds on the NSCEB’s Biotech Across America Roadshow, fostering collaboration and connecting regional biotech hubs from around the country in a forum to compare approaches, identify shared challenges, and highlight strategies that can be adapted or scaled across different regions to a build stronger national biotechnology ecosystem.

The Engineering Biotechnology Research Consortium (EBRC) and the Federation of American Scientists (FAS) co-hosted the event, held at the FAS offices in Washington, D.C.

“Since launching our report in April 2025, the NSCEB has been on the Biotech Across America Roadshow, traveling around the country highlighting the people and places that are driving the growth of the American biotech industry,” said NSCEB Vice Chair Michelle Rozo. “Today’s State Symposium is an opportunity to invite biotech leaders from all 50 states to come together to share their experiences and learn from each other’s creativity and expertise. As we urgently work to implement forward-looking biotech policy in Washington, we are grateful to have partners across the country who are dedicated to ensuring the U.S. succeeds as the global biotech leader.”

“The future of U.S. biotechnology will be shaped not just in Washington, but in states and regions across the country,” said India Hook-Barnard, CEO of EBRC. “This symposium highlighted the critical role that they play in building talent, advancing innovation, and ensuring the United States remains globally competitive.”

“It is important to remember that federal priorities are not synonymous with national priorities. The work of building a vibrant bioeconomy does not begin and end with a single administration. Authority and influence exist at multiple levels — in states and municipalities, in research norms, and in civil society,” says Dr. Jedidah Isler, Chief Science Officer, Federation of American Scientists

Event details:

Speakers and panelists focused on three cross-cutting areas that consistently shape state and local biotechnology success: the biotech talent pipeline, biotech product commercialization, and efforts to increase bioliteracy in both the public and among policymakers. Presentation of successful case studies accompanied panel discussions for each topic.

Continue Reading